Two Sigma Advisers’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,096
| Closed | -$50.9K | – | 2374 |
|
|
2023
Q2 | $50.9K | Sell |
2,096
-1,032
| -33% | -$25.1K | ﹤0.01% | 2274 |
|
|
2023
Q1 | $68.3K | Sell |
3,128
-172
| -5% | -$3.76K | ﹤0.01% | 2421 |
|
|
2022
Q4 | $78.6K | Sell |
3,300
-1,400
| -30% | -$33.4K | ﹤0.01% | 2323 |
|
|
2022
Q3 | $129K | Buy |
4,700
+212
| +5% | +$5.82K | ﹤0.01% | 2274 |
|
|
2022
Q2 | $136K | Buy |
4,488
+1,980
| +79% | +$60K | ﹤0.01% | 2353 |
|
|
2022
Q1 | $135K | Buy |
2,508
+1,876
| +297% | +$101K | ﹤0.01% | 2449 |
|
|
2021
Q4 | $188K | Sell |
632
-28
| -4% | -$8.33K | ﹤0.01% | 2300 |
|
|
2021
Q3 | $256K | Buy |
+660
| New | +$256K | ﹤0.01% | 2175 |
|